Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Cancer Immunology, Immunotherapy : CII
|
January 1, 1989
Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens
P Fuschiotti, M C Fioretti, L Romani, et al.
Pharmacological Research Communications
|
May 1, 1988
Regulation of tumor antigen expression by drugs acting as mutagens and/or gene activators
P Fuschiotti, P Puccetti, L Romani, et al.
The Journal of General Virology
|
September 12, 2006
Development of the dodecahedral penton particle from adenovirus 3 for therapeutic application
P Fuschiotti, P Fender, G Schoehn, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide
P Ballerini, A Franchi, P Fuschiotti, et al.
Immunogenetics
|
June 20, 1998
High RAD51 mRNA levels in young rabbit appendix. A role in B-cell gene conversion?
E Schiaffella, P Fuschiotti, S J Bensinger, et al.
Pharmacological Research
|
February 1, 1992
Genomic aspects of drug-induced xenogenization of murine tumors
P Fuschiotti, U Grohmann, M Allegrucci, et al.
Clinical & Experimental Metastasis
|
May 1, 1989
Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative
M Allegrucci, P Fuschiotti, P Puccetti, et al.
Pharmacological Research
|
September 1, 1990
Biochemical aspects of mutagen-induced antigenicity
U Grohmann, P Fuschiotti, R Bianchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1997
RAG1 and RAG2 in developing rabbit appendix subpopulations
P Fuschiotti, M G Fitts, R Pospisil, et al.
Pharmacological Research
|
September 1, 1992
Molecular and genomic aspects of xenogenizing-alkylating drugs
M Allegrucci, U Grohmann, P Fuschiotti, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Cancer Immunology, Immunotherapy : CII
|
January 1, 1989
Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens
P Fuschiotti, M C Fioretti, L Romani, et al.
Pharmacological Research Communications
|
May 1, 1988
Regulation of tumor antigen expression by drugs acting as mutagens and/or gene activators
P Fuschiotti, P Puccetti, L Romani, et al.
The Journal of General Virology
|
September 12, 2006
Development of the dodecahedral penton particle from adenovirus 3 for therapeutic application
P Fuschiotti, P Fender, G Schoehn, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide
P Ballerini, A Franchi, P Fuschiotti, et al.
Immunogenetics
|
June 20, 1998
High RAD51 mRNA levels in young rabbit appendix. A role in B-cell gene conversion?
E Schiaffella, P Fuschiotti, S J Bensinger, et al.
Pharmacological Research
|
February 1, 1992
Genomic aspects of drug-induced xenogenization of murine tumors
P Fuschiotti, U Grohmann, M Allegrucci, et al.
Clinical & Experimental Metastasis
|
May 1, 1989
Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative
M Allegrucci, P Fuschiotti, P Puccetti, et al.
Pharmacological Research
|
September 1, 1990
Biochemical aspects of mutagen-induced antigenicity
U Grohmann, P Fuschiotti, R Bianchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1997
RAG1 and RAG2 in developing rabbit appendix subpopulations
P Fuschiotti, M G Fitts, R Pospisil, et al.
Pharmacological Research
|
September 1, 1992
Molecular and genomic aspects of xenogenizing-alkylating drugs
M Allegrucci, U Grohmann, P Fuschiotti, et al.
Page
of 2